XI'AN, China, Feb. 5 (UPI) -- Worldwide said Monday the Chinese Food and Drug Administration approved its hepatitis C diagnostic kit.
The company said the product, known as "diagnostic kit to hepatitis C antibody," is the only diagnostic test developed from intact HCV virus, which could improve accuracy and diagnostic window compared to other tests.
"This transition is a critical milestone of our growth strategy to become the leading figure in the research & development of HCV diagnostics and therapeutics," said Wenxia Guo, Worldwide's president and chief executive officer.
"Our ability to release a highly sensitive and accurate HCV diagnostic product based on the intact HCV virus, that we cultured, strongly enhances the leading position of our company in HCV research," Guo added.
Worldwide said it has already commenced the large-scale production and sale of its test.
